Skip Navigation


IJE Advance Access originally published online on August 8, 2005
International Journal of Epidemiology 2005 34(5):1123-1128; doi:10.1093/ije/dyi160
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
34/5/1123    most recent
dyi160v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vaccaro, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaccaro, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2005; all rights reserved.

Genetics

Enhanced Na–Li countertransport: a marker of inherited susceptibility to type 2 diabetes

Olga Vaccaro1,*, Vincenzo Cuomo1, Maurizio Trevisan2, Massimo Cirillo3, Walter Panarelli4, Martino Laurenzi5, Mario Mancini1, Gabriele Riccardi1 On behalf of the Gubbio Study Research Group

1 Department of Clinical and Experimental Medicine, Federico II University of Naples, Napoli, Italy
2 School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
3 Nephrology, Second University, Naples, Napoli, Italy
4 Gubbio Hospital, Gubbio, Italy
5 Center of Epidemiological Research, Merck Sharp & Dohme, Italy

* Corresponding author. Department of Clinical and Experimental Medicine, Via S Pansini 5, 80131–Naples, Italy. E-mail: ovaccaro{at}unina.it

Introduction The association between type 2 diabetes and hypertension has long been described, but the mechanisms remain unclear. Na–Li countertransport (Na–Li CT) activity is viewed as a marker of inherited pre-disposition to hypertension, especially if associated with other metabolic abnormalities.

Aim To evaluate whether enhanced Na–Li CT activity is a predictor of type 2 diabetes.

Methods Study participants were 2167 men and women, 30–70 years. Na–Li CT activity, glucose, HDL cholesterol, blood pressure, height, and weight were measured. Six years incidence of diabetes (WHO) was assessed.

Results Baseline Na–Li CT activity was significantly higher for people who developed diabetes at follow-up (n = 101) than for those who remained non-diabetic (364 ± 184 vs 300 ± 150 µmol/l RBC/h, P < 0.001). This finding was confirmed after correction for obesity, hypertension, and blood glucose. Six years' incidence of diabetes increased across tertiles of baseline Na–Li CT activity—from 2 to 7%—with a significant linear trend (P < 0.001). In multivariate analyses Na–Li CT is a significant predictor of diabetes independent of age, BMI, HDL cholesterol, hypertension, and plasma glucose; based on exponentiation of the regression coefficient Na–Li CT higher by 154 µmol (i.e. 1 SD of the population mean) was associated with a 36% greater risk of incident diabetes.

Conclusions Prospective data from the present study show for the first time enhanced Na–Li CT activity is a significant predictor of development of diabetes in adults, thus suggesting that it could be viewed as a pre-clinical, possibly genetic, marker of inherited susceptibility to type 2 diabetes.


Keywords Countertransport, hypertension, insulin resistance

Accepted 14 July 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.